But as GLP-1 use rapidly expands at the same time access to primary care is shrinking, it is reasonable to worry whether overstretched clinicians will be able to adapt or whether many people will still be left to navigate their weight-loss journey on their own
GLP-1 RAs also slows down your gastric emptying and sends signals to your brain that reduce your appetite so you feel full longer
That makes it cheaper to manufacture and avoids some of the drug interaction concerns
These could include an individuals genetics, current health status, GLP-1 dose, and other medications they take
Foods you previously found irresistible now seem merely acceptable
Furthermore, the Endocrine Societys obesity guideline recommends that patients with obesity in the absence of diabetes should discontinue weight-loss medications if safety or tolerability issues arise, and consider other therapeutic options